• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Iodine Software, OpenAI Partner to Resolve Revenue Leakage

Share:

July 3, 2023

Iodine Software, a healthcare AI technology company, has announced an expanded relationship with OpenAI, gaining access to OpenAI’s cutting-edge artificial intelligence technologies, including the powerful language model GPT-4. This collaboration will enable Iodine to enhance its AwareCDI product suite with generative AI and large language models, improving prediction accuracy, streamlining queries, and developing clinical automation tools to ensure documentation accuracy. With its extensive dataset, Iodine Software aims to leverage the latest innovations in large language models to optimize patient documentation, increase coding efficiency, and improve predictive analytics in healthcare settings.

What You Should Know:

  • Iodine Software, a pioneer in healthcare AI technology, today announced an expanded relationship withOpenAI, an AI research and development company.
  • As part of this collaboration, Iodine will gain access to OpenAI’s cutting edge artificial intelligence technologies, including its powerful language model GPT-4.

AI-Driven Clinical Automation Tools

Iodine Software has a deep-rooted history in AI technology, having developed sophisticated, industry leading solutions that enhance financial performance in the mid-revenue cycle. This collaboration with Open AI allows it to further infuse generative AI and large language models across the breadth of its AwareCDI product suite to improve prediction accuracy, streamline query processes, and develop clinical automation tools that will further stem revenue cycle leakage by ensuring documentation accuracy.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“We are thrilled to collaborate with a fellow pioneer in the field of artificial intelligence,” said William Chan, Iodine CEO and co-founder, “Strategic, fast paced yet cautious innovation has always been our guiding principle. The evolution towards generative AI is a natural next step for us. We are optimistic about its potential impact, yet cautious due to the significant impact on patient care, physician trust and patient reimbursements. Aware of its limitations, such as data hallucinations, we are committed to a responsible approach, ensuring we balance progress with prudence.”

The efficacy of Artificial Intelligence is dependent on data on which the language models are trained. Iodine Software is an industry leader with an unmatched dataset that contains more than 27 percent of all U.S. inpatient data, giving the company an unprecedented opportunity to transform how it supports hospitals across a variety of functions. A recent market analysis of the volatility of CMI validated that Iodine Software’s data cohort is representative of the overall market, which makes it one of the best and powerful assets for training machine-learning and large language models.

By incorporating the latest innovations in large language models, Iodine Software can ensure more specific patient documentation and coding efficiency, increase prediction accuracy, and improve its predictive analytics. These advancements will contribute to streamlining the physician documentation experience, allowing physicians to focus more on patient care, and helping hospitals and health systems to capture more earned revenue from the care they provide.

Source: HitConsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Schweiger Dermatology Group Announces Acquisition of Southern Tier Dermatology Aesthetics with Locations Throughout Upstate New YorkSchweiger Dermatology Group Announces Acquisition of Southern Tier Dermatology Aesthetics with Locations Throughout Upstate New York
  • RadNet to Acquire DeepHealth, Inc., Expanding its Efforts in Artificial IntelligenceRadNet to Acquire DeepHealth, Inc., Expanding its Efforts in Artificial Intelligence
  • Amwell Raises $194M to Expand Telehealth Platform to Combat COVID-19 PandemicAmwell Raises $194M to Expand Telehealth Platform to Combat COVID-19 Pandemic
  • 4 Ways Healthcare Leaders Can Use Data & Analytics to Prevent, Predict and Prepare for a Pandemic4 Ways Healthcare Leaders Can Use Data & Analytics to Prevent, Predict and Prepare for a Pandemic
  • Tiziana Life Sciences Acquires a Nanoparticle-Based Formulation Technology for Controlled Delivery of Actinomycin D for Treatment of Myelodysplastic syndrome and Acute Myeloid LeukemiaTiziana Life Sciences Acquires a Nanoparticle-Based Formulation Technology for Controlled Delivery of Actinomycin D for Treatment of Myelodysplastic syndrome and Acute Myeloid Leukemia
  • Solv Raises $45M to Expand Same-Day Appts & Virtual Care Options NationwideSolv Raises $45M to Expand Same-Day Appts & Virtual Care Options Nationwide
  • Hylant Announces Exclusive Partnership With Regenexx to Reduce Orthopedic Surgical Spend for EmployersHylant Announces Exclusive Partnership With Regenexx to Reduce Orthopedic Surgical Spend for Employers
  • Viracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private PlacementViracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private Placement

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications